Search by Drug Name or NDC
NDC 43547-0283-50 TELMISARTAN 20 mg/1 Details
TELMISARTAN 20 mg/1
TELMISARTAN is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Solco Healthcare US, LLC. The primary component is TELMISARTAN.
MedlinePlus Drug Summary
Telmisartan is used alone or in combination with other medications to treat high blood pressure. Telmisartan is also used to decrease the chance of heart attack, stroke, or death in people 55 years of age or older who are at high risk for cardiovascular disease. Telmisartan is in a class of medications called angiotensin II receptor antagonists. It works by blocking the action of certain natural substances that tighten the blood vessels, allowing the blood to flow more smoothly and the heart to pump more efficiently. High blood pressure is a common condition and when not treated, can cause damage to the brain, heart, blood vessels, kidneys and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.
Related Packages: 43547-0283-50Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Telmisartan
Product Information
| NDC | 43547-0283 |
|---|---|
| Product ID | 43547-283_85d103f4-4fba-459a-841e-961926dee65d |
| Associated GPIs | 36150070000310 |
| GCN Sequence Number | 047126 |
| GCN Sequence Number Description | telmisartan TABLET 20 MG ORAL |
| HIC3 | A4F |
| HIC3 Description | ANTIHYPERTENSIVES, ANGIOTENSIN RECEPTOR ANTAGONIST |
| GCN | 23833 |
| HICL Sequence Number | 018839 |
| HICL Sequence Number Description | TELMISARTAN |
| Brand/Generic | Generic |
| Proprietary Name | TELMISARTAN |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | TELMISARTAN |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 20 |
| Active Ingredient Units | mg/1 |
| Substance Name | TELMISARTAN |
| Labeler Name | Solco Healthcare US, LLC |
| Pharmaceutical Class | Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA207882 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 43547-0283-50 (43547028350)
| NDC Package Code | 43547-283-50 |
|---|---|
| Billing NDC | 43547028350 |
| Package | 500 TABLET in 1 BOTTLE (43547-283-50) |
| Marketing Start Date | 2017-08-20 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |